# NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

> Federal funding opportunity · **POSTED** · National Institutes of Health · close: **01/07/2027**

## Key facts

- **Opportunity ID:** 357543
- **Opportunity number:** PAR-25-026
- **Agency:** National Institutes of Health
- **Status:** posted
- **Document type:** synopsis
- **Open date:** 12/05/2024
- **Close date:** 01/07/2027
- **CFDA codes:** 93.840, 93.233, 93.839, 93.837, 93.838

## Primary source

Grants.gov opportunity detail: https://www.grants.gov/search-results-detail/357543

## Citation

> US Grants.gov, funding opportunity 357543 (PAR-25-026). Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/opportunity/357543. Licensed CC0.

---

*[Grants.gov dataset](/datasets/grants-gov) · CC0 1.0*